Thyrocare IPO oversubscribed 73x

Please Share::

Thyrocare Technologies Limited
Sr.No.	Category	No.of shares offered/reserved	No. of shares bid for - NSE	No. of shares bid for
1	Qualified Institutional Buyers (QIBs)	2148942	104813115	157252095
1(a)	Foreign Institutional Investors(FIIs)		54942525	69781041
1(b)	Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)		21872202	56655720
1(c)	Mutual funds		22088121	23581503
1(d)	Others		5910267	7233831
2	Non Institutional Investors	1611707	139576470	363122892
2(a)	Corporates		51348957	178505679
2(b)	Individuals(Other than RIIs)		85942890	176932305
2(c)	Others		2284623	7684908
3	Retail Individual Investors(RIIs)	3760648	12980682	32822724
3(a)	Cut Off		10567656	28670598
3(b)	Price bids		2413026	4152126
	Total	7521297	257370267	553197711

�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

��

-->

Mirroring strong investor demand, the initial public offering (IPO) of diagnostics company Thyrocare Technologies was oversubscribed 73.46 times on the last day of the offer on Friday. The Rs 479.21-crore IPO received bids for 55.25 crore shares against the total issue size of 75,21,297 shares, as per data available till 1900 hrs. The category reserved for qualified institutional buyers (QIBs) was oversubscribed 73.18 times, while non-institutional investors received 225.30 times subscription. Retail investors portion was also oversubscribed 8.55 times. The firm, which runs a diagnostics laboratory chain, has come out with a public issue of up to 10,744,708 shares of Rs 10 each. It has fixed a price band of Rs 420-446 for the issue. The company will garner around Rs 479.21 crore at the upper end of the price band. Thyrocare has raised Rs 144 crore through issuance of shares to 15 anchor investors. The shares are proposed to be listed on NSE and BSE. The issue is being managed by JM Financial Institutional Securities, Edelweiss Financial Services and ICICI Securities. Thyrocare competes with diagnostics chains such as Dr Lal PathLabs, SRL Diagnostics, Metropolis Healthcare and Apollo Clinic.